ANZDATA 2013 Report Chapter 2 New Patients.pub

First Page		Document Content
Date: 2014-05-06 04:28:34 Anatomy Diabetes Chronic kidney disease Glomerulonephritis Diabetic nephropathy IgA nephropathy Nephropathy Comorbidity Diabetes mellitus Kidney diseases Medicine Health		ANZDATA 2013 Report Chapter 2 New Patients.pub Add to Reading List Source URL: www.anzdata.org.au Download Document from Source Website File Size: 454,56 KB Share Document on Facebook

	Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro DocID: 1uEgV - View Document
	Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro DocID: 1uvxq - View Document
	fs004:20 AM DocID: 1rhmX - View Document
	Opportunity for Human Research Subjects SONAR: Study of Diabetic Nephropathy with Atransentan. Category DocID: 1qwKJ - View Document
	J Am Soc Nephrol 12: 1001–1009, 2001 Diabetes Insipidus in Uricase-Deficient Mice: A Model for Evaluating Therapy with Poly(Ethylene Glycol)-Modified Uricase SUSAN J. KELLY,* MARIELLE DELNOMDEDIEU,‡ MICHAEL I. OLIVE DocID: 1qiQw - View Document